Christopher Geissler

Christopher Geissler is currently serving as the Commercial Lead for the Gene & Cell Therapy Portfolio at GenScript, a position held since May 2019, focusing on GMP grade sgRNAs and non-viral payloads. Prior to this role, Christopher held various positions at St. Luke's University Health Network from June 2016 to March 2019, including Sales Account Manager, Inside Sales Manager, and Mental Health Technician. Christopher earned a Bachelor of Science in Molecular Biology from Lehigh University in May 2018 and is currently pursuing a Master of Business Administration with a concentration in Finance at Lehigh University College of Business, expected to graduate in January 2025.